#25 - Matt Wetzel: FDA Isn't the Finish

www.lifeblood.com

Hosted by Giovanni Lauricella, in this episode we interview Matt Wetzel, Partner at Goodwin. Matt shares his industry expertise of legal and compliance issues as a legal representative of MedTech companies. Giovanni and Matt discuss changes and impacts from the current Presidential administration to the MedTech industry, regulatory reform, FDA layoffs, MedTech representation in Washington, DC, hotels and shamans, and more.

This episode is sponsored by Goodwin, a lifecycle legal firm with a specialized MedTech practice. To learn more about Goodwin's MedTech practice, visit www.goodwinlaw.com/en/people/g/gomez-martin or by emailing Martin Gomez directly at mgomez@goodwinlaw.com

Chapters

• 0:00 Intro
• 1:31 Hotels, Shamans, and Self-Discovery
• 29:27 Who is Matt Wetzel?
• 37:38 Inside the MedTech Legal World
• 1:09:29 Washington, DC and the MedTech Industry
• 1:23:25 Tariffs, Trade, and Global Strategy
• 1:30:33 Regulatory Reform and Long-Term Vision
• 1:33:40 FDA Layoffs and Industry Perception
• 1:48:00 China, Biotech, and Global Risk
• 1:54:52 Government Affairs and Early-Stage MedTech
• 2:12:34 What Goodwin Does for MedTech
• 2:29:56 General Counsel vs Law Firms